CA Patent

CA2343934A1 — Short peptides which selectively modulate the activity of protein kinases

Assigned to Yissum Research Development Co of Hebrew University of Jerusalem · Expires 2000-04-06 · 26y expired

What this patent protects

Peptides which are peptide derivatives of the .alpha.D region of a protein kinase can modulate the activity of protein kinases. The activity of a prote in kinase in a subject can be modulated by administering one or more of these peptides.

USPTO Abstract

Peptides which are peptide derivatives of the .alpha.D region of a protein kinase can modulate the activity of protein kinases. The activity of a prote in kinase in a subject can be modulated by administering one or more of these peptides.

Drugs covered by this patent

Patent Metadata

Patent number
CA2343934A1
Jurisdiction
CA
Classification
—
Expires
2000-04-06
Drug substance claim
No
Drug product claim
No
Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.